KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Other Operating Expenses: 2013-2025

Historic Other Operating Expenses for Emergent BioSolutions (EBS) over the last 8 years, with Sep 2025 value amounting to $102.2 million.

  • Emergent BioSolutions' Other Operating Expenses rose 58.94% to $102.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.4 million, marking a year-over-year decrease of 20.45%. This contributed to the annual value of $24.3 million for FY2024, which is 67.25% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Other Operating Expenses of $102.2 million as of Q3 2025, which was up 22.98% from $83.1 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Other Operating Expenses peaked at $513.4 million during Q2 2023, and registered a low of -$40.0 million during Q2 2024.
  • For the 3-year period, Emergent BioSolutions' Other Operating Expenses averaged around $125.1 million, with its median value being $102.2 million (2025).
  • The largest annual percentage gain for Emergent BioSolutions' Other Operating Expenses in the last 5 years was 9,285.71% (2024), contrasted with its biggest fall of 107.79% (2024).
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Other Operating Expenses stood at $305.2 million in 2021, then decreased by 19.69% to $245.1 million in 2022, then decreased by 17.87% to $201.3 million in 2023, then slumped by 33.28% to $134.3 million in 2024, then skyrocketed by 58.94% to $102.2 million in 2025.
  • Its Other Operating Expenses was $102.2 million in Q3 2025, compared to $83.1 million in Q2 2025 and -$12.2 million in Q1 2025.